5 Výsledek
FIELD OF THE INVENTION
This invention is in the field of treatment of alphavirus infection.
BACKGROUND OF THE INVENTION
The family Alphaviridae includes influenza viruses, parainfluenza viruses, picornaviruses, polio virus, flaviviruses, e.g. yellow fever virus, the four serotypes of dengue virus,
FIELD OF THE INVENTION
This invention is in the field of treatment of alphavirus infection.
BACKGROUND OF THE INVENTION
The family Alphaviridae includes influenza viruses, parainfluenza viruses, picornaviruses, polio virus, flaviviruses, e.g. yellow fever virus, the four serotypes of dengue virus,
FIELD OF THE INVENTION
This invention relates to a method for providing .alpha.-glucosidase inhibition to a subject by administering a pharmaceutical composition comprising a .alpha.-glucosidase inhibitory agent selected from pipataline (formula 1a), sesamin (formula 1b), pellitorine (Formula 1c),
This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as
This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as